# BioCatch

BioCatch is an Asset Manager based in Tel Aviv, Israel.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Tel Aviv, Israel
- **Assets under management:** Undisclosed
- **Website:** www.biocatch.com

## Regulatory record

- **Reports private funds:** No

## About

BioCatch is a global leader in digital fraud detection and financial crime prevention powered by behavioral biometric intelligence. Its BioCatch Connect platform unites real-time telemetry, behavioral analysis, and predictive intelligence to detect and prevent account opening fraud, account takeover, social engineering scams, and mule accounts. The company analyzes thousands of user interactions and collects more than 3,000 anonymized data points to distinguish criminal from legitimate behavior for banks and financial institutions.

## Sectors

- Cybersecurity
- Enterprise Software
- FinTech
- AI/ML

## People

- Gadi Mazor — Chief Executive Officer
- Itai Novick — Chief Science Officer
- Greg Stockett — Chief Financial Officer
- Amelia Ahlgren Lurie — Chief Strategy Officer
- Mike Keating — Chief Revenue Officer
- Ayelet Eliezer — Chief Product Officer
- Eyran Blumberg — Chief Operating Officer
- Oran Tamir — Chief R&D Officer

## Questions

### Who runs investment decisions at BioCatch?

BioCatch is an operating company, not an investment firm. All strategic and financial decisions are managed by its internal leadership team, led by CEO Gadi Mazor. Greg Stockett, the Chief Financial Officer, oversees capital allocation and financial management. The firm has not publicly disclosed a formal investment committee or separate investment arm.

### How does BioCatch source its behavioral data?

BioCatch captures behavioral telemetry directly from end-user interactions within its banking clients' digital applications. The system collects over 3,000 signals — including mouse dynamics, keystroke patterns, and navigation gestures — during live sessions. This data is processed via the firm's cloud platform, which applies behavioral sequencing and machine-learning models trained on its corpus of more than 16 billion analyzed sessions.

### Which sectors does BioCatch serve, and which does it explicitly avoid?

The firm focuses almost exclusively on financial institutions — it states its technology protects digital banking customers. There is no public evidence of deployment in non-banking verticals such as healthcare, gaming, or government identity verification, though its behavioral sequencing models are technically sector-agnostic.

### What is BioCatch's known posture on integrating with existing bank fraud stacks?

BioCatch positions its behavioral-intelligence signal as a complementary layer, not a replacement for a bank's existing fraud controls. The platform is designed to deliver a real-time risk score that banks can feed into their own decision engines, case-management systems, and step-up-authentication flows to add a behavioral-intent dimension to transaction risk analysis.

## Related profiles

- [Cantaloupe](https://altss.com/profile/cantaloupe)
- [Policygenius](https://altss.com/profile/policygenius)

---

Last updated: 2026-08-11T15:06:13.093Z

Canonical page: https://altss.com/profile/biocatch

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology